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Transmembranous Na-K active transport alteration as a genetic
marker of essential hypertension (eHT). A. Coca, J. L. Vives, M.
Marine, M. Ingelmo, A. Botey, J. Font, and A. Balcells. Servicio de
Medicina Interna, Servicio de NefrologIa, Escuela de HematologIa
"Farreras Valentl," Hospital clinico y Provincial, Facultad de Mcdi-
dna, Barcelona, Spain. Recent observations suggest that an alteration
of the transmembranous active cationic transport can be a genetic
marker of eHT. We have studied transmembranous cationic fluxes in
Nat -loaded K-dep1eted erythrocytes, blocking Na-KATPase and
Na-K cotransport activities with PCMBS and unbiocking them with
cysteine. This technique was used in a group of 40 (20 males, 20 fe-
males) healthy normotensive control subjects without a family history
of HT, in a group of 34 patients (15 males, 19 females) with eHT and
in 16 healthy normotensive offspring (8 males, 8 females) of the hyper-
tensive patients. Net cationic fluxes in the eHT group were (mean
SD, mmoles/liter cel1/hr): Na extrusion 3.54 1.02 lower than the
control (4.57 0.69) (P < 0.001) K intrusion 3.70 0.88 higher than
the control subjects (2.42 0.49) (P < 0.001) and the NaJK net flux
ratio of 0.97 0.27 lower than the control subjects (1.94 0.37) (P <
0.001). The net Na and K fluxes were linear (r = 0.99; P < 0.001).
The Na/K net flux ratio was the best discriminative parameter since
no control subject had a value lower than 1.5 and no cUT patient had
a value above it. Nine of the eHT offspring (50.25 24%) presented
the same cationic transmembranous flux alteration than their ascend-
ants, with a Na/K net flux ratio of 1.08 0.20. In the seven remain-
ing offspring, this value was 2.51 0.72 similar to the observed in the
control subjects and significantly different from the eHT group (P <
0.01). In conclusion, patients with eHT present an alteration of the trans-
membranous active cationic transport with lower Na extrusion and
higher K intrusion after "in vitro" saline overload. This alteration
can be detected in 50% of their normotensive offspring, suggesting a
genetic transmission rather than an acquired defect.
Influence of blood transfusions (BT) on T-lymphocyte subsets in ure-
mic patients. J. M. Grind, A. Caraips, M. Mestre, E. Buendia, S. Gil-
Vernet, R. Sabater, A. M. Castelao, and]. Alsina. Hospital de Bell-
vitge "Princeps d'Espanya," Barcelona, Spain. Multiple BT induce
high allograft survival in kidney transplant recipients, but the
mechanism(s) of this beneficial effect are not clearly understood and in-
crease in suppressor activity and anti-idiotipic antibodies have been in-
voked. In our unit patients awaiting a kidney cadaveric allograft re-
ceive five planned BT (packed red cells) at 15-day intervals. We have
studied T-lymphocyte subsets in 31 uremic patients on chronic hemodi-
alysis immediately before and 15 days after the end of a transfusion
program using monoclonal antibodies (OKT series). The patients had
never been transfused before this study. Three different patient sub-
groups were observed according to OKT4IOKT8+ cell ratio varia-
tions after (BT). In 13 patients (42%) there was a clear reduction in
OKT4IOKT3 ratio after BT compared with pretransfusion values: 1.8
0.7 versus 0.9 0.4 (P < 0.005), due to a marked decrease of OKT4
cells: 38 11.1 versus 21.1 5.7 (P < 0.001). In nine patients
(29%) there were no variations of OKT4/OKT5 ratio after BT (1.2
0.3 versus 1.2 0.2). in nine patients (29%) there was an increase of
OKT.110KT8 ratio after BT compared with pretransfusion values: 1.1
0.3 versus 2 0.7 (P < 0.025), due to a significant increase in OKT4
cells: 27.5 7.2 versus 37.1 5.4 (P < 0.025). There were no signifi-
cant variations of OKT8 cells in any group. Our results show that BT
may induce changes in OKT4/OKT8 ratio mainly due to variations in
the OKT4+ cell subset. More data are needed to know if these T-cell
subsets variations may influence future graft outcome.
2SOHD levels in patients on dialysis. J. L. Miguel Alonso, M. E.
Martinez, A. Rodriguez Car,nona, R. Selgas, G. Balager, A. Car-
rasco, M. Ibarra, J. Martinez Ara, and L. Sanchez Sicilia. Ciudad
Sanitaria La Paz, Madrid, Spain. 250HD serum levels were measured
(by protein competition, previously extracted by HPLC in 21 patients
who were on long-term dialysis for 12 to 41 months; 12 were on HD
and 9 on CAPD. None had hepatic dysfunction. pH, ionic calcium
(Ca ) (Ionic Calcimeter Radiometer), phosphorus, magnesium, al-
kaline phosphatase, and PTH-C were simultaneously determined.
CAPD patients received a 0.5 to 1.5 g calcium diet supplement. The
results showed that 250HD serum levels less than 10 ng/ml were pres-
ent in 40% of the CAPD patients and in only 10% of the HD patients,
but no statistical difference was present when both means were com-
pared. Calcium serum levels in CAPD patients were below normal val-
ues despite the calcium supplement. The rest of the parameters com-
pared were similar between both groups. in conclusion, CAPD may in-
duce low levels of 250HD which in turn decreases the serum Ca
despite all the efforts made to improve calcium balance. Our results
may point out the need of 250HD supplements in CAPD patients for
the reason aforementioned and for others not well-defined due to the
lack of knowledge of its complete action.
Ureteropelvic fibrosis in renal allograft. S. Gil-Vernet, J. M. Griñó,
A. Caralps, A. M. Castelao, R. Sabater, and J. Alsina. Division of
Nephrology, Bellvitge Hospital "Princeps d'Espanya," Barcelona,
Spain. Ureteral obstruction occurs in I to 15% of renal allograft. How-
ever, ureteropelvic fibrosis is an uncommon cause of obstruction. We
report eight new patients with this complication. From May 1980 to
October 1983, 100 renal allografts were performed at the Bellvitge Hos-
pital, 90 from cadaveric donors and 10 from living related donors. We
describe eight patients with ureteropelvic fibrosis (8%). All of them
were diagnosed on clinical, radiographic, and ultrasound examina-
tions. The etiology is unclear. Three patients presented a vascular re-
jection, one a wound infection. In four patients biopsy specimens
showed ureteric fibrous bands; two of them revealed intracellular in-
clusions characteristic of silicon granules. A uretero-pyelostomy was
done in three patients and reimplantation of the ureter in five. The long-
term evolution was good in five patients (mean serum creatinine = 160
tmoles/liter) and three returned to hemodialysis by vascular rejection.
Platelet function in chronic uremia: Effect of hemodialysis. X. Sar-
rias, F. Martinez-Brotons, J. Gabds, and J. Alsina. Servicio de
Nefrologia y Hematolqgia, Hospital de Bellvitge "Princeps
d'Espanya," Barcelona, ervicio de Nefrologia, Alianca Mataronina,
Matard, Spain. in 1982 a paradoxical arachidonic acid (AA) metabo-
lism in platelets of uremic patients was described. We studied 15 pa-
tients on maintenance hemodialysis immediately before and 3 hr after
the start of a routine dialysis and compared the results with a control
group. Platelet production of thromboxane B2 (TxB2) and malondialde-
hyde (MDA) in response to AA (0.25 to 0.5 and 1 mM), '4C-5-
hydroxytryptamine ('4C-5HT) uptake and AA and collagen-induced se-
cretion were measured, and also the percentage aggregation in re-
sponse to these agents. The results were that before hemodialysis,
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MDA and TxB2 synthesis in response to low AA concentrations (0.25
and 0.5 mM) were moderately enhanced, but significantly reduced (P
< 0.001) at the highest concentration. After dialysis, reduced gener-
ation at high AA concentration was fully corrected (P < 0.001), while
production in response to low AA concentrations showed only a mod-
erate increase (P < 0.02). Before dialysis '4C-SHT secretion and plate-
let aggregation in response to AA were both clearly reduced (P <
0.001). In the postdialysis measure only a light increase was found (P
<0.4). In conclusion, hemodialysis enhances the MDA and TxB2 pro-
duction, especially at high concentrations of AA. Nevertheless, AA in-
duced aggregation and secretion are not corrected, suggesting a more
complex abnormality.
Can $.thromboglobulin levels during hemodialysis reflect the biocom-
patibility of the dialyser? A. Mart Inez-Malo, F. Velasco, P. Andres, R.
Perez, J. GOmez, E. Moreno, E. Andres, L. G. Burdiel, A. Torres, and
P. Aljama. Ciudad Sanilaria "Reina Sofia," COrdoba, Spain. The
interaction between blood and dialyser induces platelet activation
which results from deficient biocompatibility. Since systemic anti-
coagulation does not modify /3-thromboglobulin (B-TG) concentra-
tions, this parameter is a reliable guide to platelet activity during he-
modialysis (HD). We have therefore related the plasma B-TG levels
with another well known index of biocompatibility such as the neu-
trophil count changes during HD. We studied nine regular HD pa-
tients sequentially treated with cuprophan (CU), ethylene-vinyl-alco-
hol (EVAL), and polyacrylonitrile (AN-69) membrane dialysers. B-TG
concentrations and neutrophil counts were determined at 0, 15, and 60
mm from the start of HD in the arterial line as well as at 15 mm in the
venous line. CU induced a profound neutropenia at 15 mm (16% of
starting value) which was associated with a significant increase in
plasma B-TG (+ 11%; P < 0.005). During HD with EVAL there was a
moderated decrease in neutrophil count (59% of starting value) and B-
TG levels slightly rose (+ 7%; P < 0.05). With AN-69 membrane there
were no significant changes in neutrophil counts and B-TG concentra-
tions remained steady (+ 3%; P = NS). Considering the three groups
of data as a whole, the decrease in neutrophil count correlated with the
rise in B-TG (r = 0.87). We conclude that the plasma B-TG concen-
trations during HD reflect the degree of biocompatibility of the di-
alyser membrane.
Pathogenesis of glomerular fibrin deposition role of the contact sys-
tem. J. Villaro, P. Errasti, M. Gobi, A. MonzOn, A. Purroy, and A.
Sdnchez-Ibarro/a. C/mica Universitaria, Pamplona, Spain. We in-
duced a severe type of anti-GBM serum nephritis in normal Wistar rats
and Brown Norway rats (BN/Mai Pfd) deficient in plasma prekalli-
krein and high-molecular weight kininogen. This latter group of ani-
mals developed proliferative changes with a high percentage of cres-
cents and intense glomerular fibrin deposition. The cortical fibrinolytic
activity, measured by the fibrin-slide technique, was increased in nor-
mal and deficient rats. These findings suggest that the contact activa-
tion system of coagulation does not play a decisive role in glomerular
fibrin deposition nor in the enhancement of fibrinolytic activity in the
kidney cortex. Immunofluorescent evidence of mesangial uptake of fi-
brin and fibrin-related antigens (FRA) in tubular handling is presented.
These data could help in the understanding of glomerular fibrin clear-
ance mechanisms and the meaning of urinary FRA.
Antibody to hepatitis B core antigen in hemodialysis patients. J. Car-
rio, R. Pascual, J. M. Mallafre, J. Roma, and J. A. Oliva. Nephrol-
ogy Service, Hospital de Ia Cruz Roja, Barcelona, Spain. A group of
27 patients with chronic renal failure on maintenance hemodialysis
were screened monthly for hepatitis B surface antigen (HBs Ag), hepa-
titis B core antibody (anti-HBc), and hepatitis B surface antibody (anti-
HBs) by enzyme immunoassay, over a 12-month period. Four patients
became HBs Ag positive (+), two of them transiently and two perma-
nently. All four of these patients developed + anti-HBc persistently,
but only one of them turned anti-HBs -i-. Ten additional patients were
at some point anti-HBc + in the persistent absence of HBs Ag. In this
group often anti-HBc +IHBs Ag negative patients, anti-HBc was per-
sistently -- in three and intermittently + in seven. Only three of the
patients in this group developed anti-HBs. Thus, of the total 14 pa-
tients who became anti-HBc +, only four (28, 5%) ever developed
anti-HBs. No relation between positivity for anti-HBc and elevation of
serum aminotransferases was found. The results suggest that: (1) the
incidence of anti-HBc + in hemodialysis patients is higher (5 1%) than
in the general population from the same area (18%). (2) Anti-HBc in
hemodialysis patients can be intermittently +, perhaps reflecting vari-
ations in titer. (3) Seventy-one percent of anti-HBc + hemodialysis pa-
tients seem to be unable to produce protective anti-HBs. This might
be due to impaired immune response to the hepatitis B virus in this
population. An alternative explanation could be that anti-HBc is a
marker that cross-reacts with other substances similar to the hepatitis
B virus core antigen, such as the viral hepatitis non-A non-B core an-
tigen.
Chronic hepatic disease (CHD) in renal allograft recipients. J. L. Mo/I,
D. Carrasco, L. PallardO, M. Prieto, M. Rayon, J. M. Escobedo, M.
Olmos, and J. M. Cruz. Servicio de Nefrologia CS. La Fe," Val-
encia, Spain. We have studied the prevalence of CHD in 23 renal al-
lograft recipients. Biochemical hepatic tests including postprandial se-
rum bile acids (SBA) and virological screening were determined.
Twelve patients showed increased levels of ALT/AST twice normal at
least for 6 months; in eight a hepatic biopsy was performed. The histo-
logical findings were: Minimal changes in three, hemosiderosis (Hs) in
one, chronic persistent hepatitis in two, and chronic active hepatitis
(CAH) in two, both with Hs. HBsAg was detected in one patient and
isolated HBcAb in another two. SBA were markedly increased in
CAH, but ALT/AST were not predictive of histological severity. Hs
was related with a longer stay in dialysis (k: 11 y), blood transfusions
(>10) and parenteral iron, but not with the presence of HLA3, B7, B14
antigens. Eighty-three percent of the patients showed increased levels
of ALT/AST before the transplantation. In conclusion, CHD was fre-
quently found in our transplant population; SBA was the most predic-
tive biochemical test of histological severity. The high prevalence of
hepatic disease in dialysis suggests that CHD is usually previous to
transplantation.
Donor-specific blood transfusions prior to living related kidney trans-
plant. S. Gil-Vernet, M. J. Rican, A. Camps, J. M. GriflO, J. Andreu,
and J. Alsina. Hospital de Bellvitge "Princeps d'Espanya," UTR
Clinic Barcelona, Spain. Since 1981, 14 potential renal allograft recipi-
ents have received three stored donor-specific blood transfusions
(DST) of 150 cc through the first month after donation. Serum from the
recipient was obtained before each blood transfusion and also, prior to
transplantation. Cross-match testing was performed against donor T
and B cells at 4 and 37°C. Cytotoxic antibody screens were also car-
ried out in each transfusion. There was no increase in widely reactive
lymphocytotoxic antibody. Three patients had a positive B cross-
match at 37°C and the transplantation was not performed. Another pa-
tient had a positive B cross-match at 4°C. The transplantation was done
in 11 patients, 7 males and 4 females, aged 9 to 36. Nine patient-donor
pairs were HLA one-haplotype mismatched and two two-haplotype
mismatched. Mixed lymphocyte cultures were not used as criteria to
be included in this study. Eight patients had received previous third-
party blood transfusions. Nobody received prednisone until the first re-
jection episode was diagnosed. There was an early acute rejection epi-
sode in ten patients and another one presented it at day 45. Two pa-
tients lost their renal allograft by vascular rejection. The graft survival
was 82% in the first years; serum creatinine was x = 116 34
moles/liter. In our experience 21% of recipients developed sensitiza-
tion to their blood donor. The allograft survival (82% in the first year)
can be better than in cadaveric allografts.
Hemodynamic and renal effects of sodium orthovanadate in the rat. M.
C. Garrido and J. M. Lopez Novoa. Laboratory of Renal Physiopa-
thology, Department of IVephrology, Fundacion Jimenez Diaz,
Madrid, Spain. Cardiac output (CO), organ blood flow, vascular resist-
ances, and glomerular filtration rate (GFR) were measured in 20 Wis-
tar rats (250 to 500 g) using radioactive microspheres and clearance
techniques, before and after an intravenous pulse of sodium orthovan-
adate (10 moles/kg). Rats were previously subjected to an extracel-
lular volume expansion equivalent to 2% of body weight. Vanadate in-
fusion induced an abrupt fall of arterial pressure and heart rate; four
rats died in cardiorespiratory failure. After recovery, the remaining 16
rats reached arterial pressures higher than those of the basal period
(119.7 + 5.1 vs. 109.8 + 5.0 mm Hg P < 0.05) CO decreased from
220 Abstracts
114 + 6 to 54.9 + 3.4 ml• mm' (P < 0.005) and total peripheral re-
sistances increased from 1.01 + 0.07 to 2.38 + 0.23mm Hg• mL' mm(P < 0.005). Heart rate decreased from 435 19 to 362 + 22
beats/mm. Blood flow was found decreased in every organ studied;
minimal changes occurred in the thick intestine (29%) and cerebral BF
(23%). The maximal decrease (57%) was exhibited by renal blood flow.
GFR decreased by 44.7% whereas total sodium excretion increased by
42.5%, and fractional sodium excretion rose from 0.9 + 0.1 to 6.83 +
0.86%. From these data it can be deduced that, in the rat, vanadate has
a potent natriuretic and vasoconstrictor effect, with a different sensi-
bility of each organ to its action. Both effects seem to he mediated by
its ability to inhibit NaK ATPase.
Monoclonal antibodies for sequential monitoring of T-cell subsets in re-
nal atlograft recipients. J. M. Grind, A. Caralps, M. Mestre, E.
BuendIa, R. Sabater, A. M. Castelao, and J. Alsina. Hospital de Bell-
vitge "J'rinceps d'Espanya," Barcelona, Spain. We have monitored T-
lymphocyte subpopulations in renal transplant recipients every 24 to 48
hr in the early post-transplant period, using monoclonal antibodies
(OKT series: OKT4 detects helper subset and OKT8 detects suppres-
sor-cytotoxic subset). Patients were treated with azathioprine 2.5
mg/kg/day and did not receive steroids prophilactically in postopera-
tive days until a rejection crisis (R) appeared; at this moment 5 mg/kg
of oral prednisone (PN) were introduced. We have studied 29 rejec-
tion episodes in 24 patients. In 24 episodes (83%) there was an in-
crease of OKT4/OKT5+ cell ratio just before (24 to 48 hr) or accom-
panying rejection with respect to previous values; lowered in all pa-
tients, and inverted in some of them, after high doses of PN: pre R.
1.33 0.48; R, 2.72 0.2. The graft outcome in some patients was
an increase in the OKT4/OKT5 ratio in relation to previous values
which may herald rejection crisis. Their variations after steroid treat-
ment may be useful to study the immune response to antirejection pro-
tocols, and thus, permit the individualization of immunosuppressive
therapy.
Lupus nephropathy: Study of antilymphocyte antibodies (ALA) and
other immunological parameters. J. Font, E. Mirapeix, J. Martorell, F.
Cardellach, A. Coca, M. Ingelmo, and A. Ba/cells. Servicio de Mcd-
icina Interna, Servicio de Nefrologia, Servicio de Inmunologla, Hos-
pital ClInico y Provincial, Facultad de Medicina, Barcelona, Spain. In
the last 3 years we carried out a prospective study in a group of 62 pa-
tients diagnosed with SLE (four or more of ARA criteria), 29 (46.80%)
of them with biopsy-proven nephropathy. The criteria of lupus activity
were considered as follows: presence of arthritis, serositis, skin rash
and/or vasculitis, active nephropathy, neurologic manifestations, he-
molytic anemia, or thrombocytopenia, either singly or in combination.
The ALA were studied with Terasaki's microcytotoxicity assay. When
the killing of cells was greater than or equal to 40%, a positive clas-
sification was given. The majority of ALA killed both T and B cells.
ALA positivity correlated significantly with clinical activity (P <
0.001), high native anti-DNA values (P < 0.001), presence of circulat-
ing immune complexes (CIC) (P < 0.02), low values of C4 (P < 0.001),
C4 (P <0.001), CH5O (P < 0.025), and with a low percentage of T sup-
pressor cells (Ty) (P < 0.01). The positivity of ALA was similar in the
group of patients with and without nephropathy (P = NS). No signifi-
cant difference was found between patients with active SLE with and
without nephropathy with respect to C, C4, CH5O, CIC, and Ty val-
ues. The anti-DNA mean value was higher in the group with nephrop-
athy (P < 0.001). The same was observed in the inactive SLE group
between patients with or without nephropathy (P < 0.025). We con-
clude that: (1) the positivity of ALA is not useful to discriminate the
presence or absence of nephropathy, and one has to rely on clinical and
immunological activity. (2) Native anti-DNA is the only immunologi-
cal parameter that permits detection of the existence of nephropathy
independent of the SLE activity.
Renal prostaglandins and urinary sodium excretion in acute postsi-
nusoidal portal hypertension in dogs. A. Mota, A. Chamorro, F.
Guarner, A. Purroy, and J. Prieto. Clinica Universitaria, tjniversidad
de Navarra, Parnp/ona, Spain. The effect of extracellular fluid expan-
sion (5% of body weight with saline) in dogs with acute postsinusoidal
portal hypertension (PPH) was studied. The ECF volume expansion in
control dogs was followed by an increase in urinary flow (1.2 0.5
mI/mm to 4.4 0.9 mI/mm; P < 0.05), sodium excretion (163.6 82jzmoles/min to 378.6 50 smoles/min; P < 0.05), and fractional so-
dium excretion (1.77 0.8% to 11.81 2.4%; P < 0.001). The ECF
volume expansion in acute PPH dogs produced an increase in urinary
flow (0.41 0.17 mI/mm to 1.51 0.6 mI/mm; P <0.05) and sodium
excretion (72.4 31 moles/min to 215.86 91 imoles/min; P <
0.05). However, fractional sodium excretion did not show any signifi-
cant change (1.38 0.9% to 2.7 2.1%). The urinary 6-keto PGFIa
showed a significant increase with ECF volume expansion in dogs with
PPH but not in control dogs. We found a correlation between urinary
6-keto PGFIa and urinary sodium excretion (r = 0.74; P < 0.05) and
between urinary 6-keto PGFIn and urinary flow (r = 0.64; P < 0.01).
It is concluded that renal prostaglandins may play an important role in
sodium handling after ECF volume expansion in dogs with postsi-
nusoidal portal hypertension.
Complement fixation "in vascular pole" in patients with glomerulo-
nephritis and primary hematuria. P. Barceló, J. A. Bal/arIn, J. Mora,
C. Gelpi, J. L. RodrIguez, and G. Del Rio. Fundacion Puigvert, Bar-
celona, Spain. Complement fixation (C3) in the vascular pole has been
described in patients with primary hematuria and in the renal vessels
of hypertensive or arteriosclerotic patients. To know its incidence, the
presence of C3 in the vascular pole has been analyzed in three groups:
(1) 81 patients with primary hematuria, without urologic pathology,
with normal blood pressure, normal renal function, and an absence of
proteinuria (0 to 0.2 g/24 hr); (2) 95 glomerulonephritis patients: focal
and segmental hyalinosis (22). membranoproliferative (18); membra-
nous (12), IgA nephropathy (37). and nonclassifiable (6); (3) nine con-
trols: specimens obtained in surgical operations (lithiasis, tumors,
cysts). Out of those with primary hematuria. in seven (11%) C3 was
found in the vascular pole and in 15 in vessels (23%). In the glomeru-
Ionephritis in five (5%), C3 was found in the vascular pole, and in nine
(9%) in vessels. In the controls C3 was not found in vessels or the vas-
cular pole. Hypertensive patients had a C3 fixation in 18% facing 3%
of normotensive patients (P < 0.001). Fixation of C3 in the vascular
pole is high in patients with primary hematuria, rare in patients with
glomerulonephritis, and absent in the controls. Hypertension in-
creases the incidence of C3 on patients with glomerulonephritis and
suggests that C3 deposits in vessels are secondary to a lesion of the vas-
cular endothelium.
High- or low-dose steroids in renal transplantatiOn. L. Pallardó, J. L.
Mo/I, J. Gracia, J. Panadero, L. MariO,, M. Alonso, M. Gull/en, and
J. M. Cruz. Servicio de Nefro/ogIa, Ciudad Saniraria La Fe, Va/en-
cia, Spain. Forty cadaveric renal allograt't recipients received azathi-
oprine 2.5 mg/kg/day and steroids in two schedules: Group A, 23 pa-
tients, were given prednisone 2 mg/kg/day reducing 10 mg/S day, and
group B, 17 patients, prednisone 30 mg/day for 2 months. Both groups
were not different in age, time on dialysis, renal disease, blood group,
pregnancies or previous blood transfusions, cytotoxic antibodies, and
HLA histocompatibility. Cumulative doses of oral prednisone were ad-
ministered 2 months after transplantation 3.843 579 mg in A and
1.800 mg in B (P < 0.01). Actuarial graft survival was at 3, 6, and 12
months, 73 versus 75%, 65 versus 67%, respectively. Four patients
died in A and none in B. The occurrence of acute rejection and intra-
venous methylprednisolone doses were similar in both groups, but
acute rejection appeared sooner in B. 5.0 1.6 days, than in A, 10.8
7.3 days (P < 0.01). The infection rate was similar in both groups
but more severe in A causing death in two patients and responsible for
a longer hospital stay during the first 6 months post-transplant in A,
48.2 24.9 days, than in B, 33.0 14.1 days (P < 0.05). In the first
year six patients in A exhibited vascular bone necrosis but the pres-
ence of hypertension was similar in both groups. In conclusion, low-
dose steroids were as effective as high-dose steroids preventing rejec-
tion and were followed by a lower rate of severe and handicapping
complications.
Influence of plasma from essential hypertensive patients (EHP) in the
22Na and 86Rb transport through the erythrocyte membrane. P. MartIn-
Vasallo, J. GarcIa-Perez, M. A. Gel/no, B. Maceira, and E. Battaner.
D. de BioquI,nica y Servicio de Nefrologla, Facu/tad de Medicina de
La Laguna, Spain. The Na-K-pump alterations in the erythrocyte
membrane of EHP are well known. However, they can be intrinsic to
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the pump, or the reset of a hypothetic circulating natriuretic factor.
The Na uptake or K extrusion, both against a concentration gradient,
can be evaluated as the ouabain inhibitory fractions of the total move-
ment of 22Na and 86Rb as a substitute of K. We have evaluated in
static (% transport inhibition) and cinetic (Kt and Vmax) ways the ef-
fect of several plasma fractions from 12 normal individuals and 15
EHP. We found a low molecular weight plasma fraction (F) in EHP
was not removed by chloroform, which modifies the transport con-
stant as follows:
EHP Controls
out F with Fwithout F with F with
86 Rb-Vmax 22.7 5.9 20.2 5.0 25.1 7.2 32.1 9.7
86 Rb-Kt 3.5 3.1 15.2 4.8 5.1 2.2 12.1 4.3
22Na-%i 0 30—50 0 30—50
Vmax. nmoles of 86Rb/ml cells hr; Kt, mM.
Disturbance in renal tubular acidification in patients with idiopathic
hypercalciuria. L. Corbacho, J. Grande, J. Maclas, andi. M. Tahern-
era. Servicio Nefrologio, Hospital C/in ico, Salamanca, Spain. Forty-
six patients suffering from idiopathic hypercalciuria (IH) were studied.
According to the normal protocol and serum levels of PTH. they were
divided as follows: excretory lH (primary renal leak of Ca) 15; absorp-
tive IH 8; lH renal loss of p 2; unclassified lH 21. In all patients pH
and acid-base balance were studied, and a short overload of NH4CI
was carried out. Thirteen patients showed metabolic acidosis (MA)
with normal GFR and no other pathological process. Net acid excre-
tion was normal in all patients. In six subjects with MA, the bicarbon-
ate threshold was studied by perfusion of IM NaHCO3; the tubular
handling of Na and H20 was studied with the Chaimowitz technique.
In all of them a decrease in the renal threshold of bicarbonate took
place: 19.9 1.32 vs. 25.0 2.29 for controls (P < 0.001). Urinary
loss of bicarbonate was greater than 10%. All were IH excretory pa-
tients. No other tubular defects were noted. Hyposaline overload: CN2,
1.53 0.38; C1120, 7.11 1.07; CNa + C1120, 8.65 1.43.
C11,0 x 100 = 82.45 1.69
CNfl + CH20
The PTH in all but one of these patients was greater than in controls.
In summary, we present a defect in renal reabsorption of bicarbonate
in IH with normal renal handling of H20 and Na. This disturbance due
to undetermined pathogenic mechanism could be related to the in-
crease in PTH.
Chronic liver disease in hemodialysis patients with VHB markers. A.
Lozano, J. Vi/ches, L. Martin, L. Peba, J. Perez, E. Fernández, and
E. Zainora. Departments of Internal Medicine and Pathology, Cadiz
University. Cadiz, Spain. Liver biopsy was performed in 19 patients
with previous HVB on hemodialysis and serologic evolution of VHB
markers controlled by RIA. No siliconed lines were used for dialysis.
Thirteen months, as a minimum, have passed from the acute phase to
liver biopsy, and 29 months was the interval mean time between the
first antigenemia and the present study. Histological features were an-
alyzed by conventional optic and phase-contrast microscopy; classi-
fication was made according to Dc Groote, Scheuer, and McSween's
criteria. Cirrhosis was present in four patients, chronic active hepatitis
(CAH) in six, and chronic persistent hepatitis (CPH) in four; the rest
of them did not show chronic liver disease (NCLD) and central sid-
erosis presented in only one of them. None had fatty changes, granu-
lomas, multinucleated giant-cells, or refractile material compatible with
silicone presence. The relationship between histological and serologi-
cal data is shown in the table.
CIRRH CAH CPH NCLD
HBsAg chronic carrier 3 1 1 2
Id+HBeAg 3 1 0 0
Id + antiHBe or HBe neg 0 0 1 2
AntiHBs 1 3 3 3
AntiHBc only 0 2 0 0
Seventy-three percent of our patients showed chronic liver disease,
with cirrhosis or CAH in half of them; only the presence of HBeAg had
correlation with poor prognostic forms. Other investigators have found
chronic liver disease in hemophilic patients and the association be-
tween VHB-antigens in the hepatocytes with anti-HBs presence in sera
was confirmed recently. Our own results confirm a chronic evolution
of hepatic injury with humoral and cellular response dissociation
caused by failure of the immunity mechanism of uremia.
Transmembranous Na-K active transport alteration: Is it useful to
discriminate essential hypertension (eHT) from secondary hypertension
(sHT) when chronic renal failure (CRF) is present? A. Coca, J. L. Vives,
M. Marine, M. Ingelmo, J. Moniolia, and A. Ba/cells. Serricio de Mcd-
icina Interna, Servicio de Nefrologia, Escuela de Hematologia Far-
reras Valenii," Hospital Clinico y Provincial, Facultad de Medicina,
Barcelona, Spain. In previous studies we evidenced that transmem-
branous Na*K active transport alteration could be a good genetic
marker of eHT that permitted differentiation of eHT from sHT. How-
ever, metabolic derangements associated with CRF can modify the ac-
tivity of various cell membrane enzymes and so the transmembranous
active cationic transport. We have studied net cationic fluxes in Na'-
loaded K-depleted human erythrocytes in 34 patients with eHT and
normal renal function and in 26 with sHT, II of them with renovas-
cular hypertension without renal failure, and the remaining 15 with
CRF and HT (Cr 8.1 4.8 mg/ill; BUN 94.1 44.3 mg/dl). Net ac-
tive Na* extrusion was 4.35 1.52 mmoles/liter cell/hr in sHT
higher than 3.54 1.02 in eHT (P < 0.02). Net active K intrusion
was 2.54 1.35 mmoles/liter cell/hr ', lower than 3.70 0.88 in eHT
(P < 0.001). The net Na'/K' flux ratio was 1.96 0.69 in sHT, simi-
lar to that of healthy normotensive controls and higher than that of
eHT (0.97 0.27; P < 0.001). Patients with sHT due to renovascular
disease had net Na'/K' flux ratios of 2.31 0.76, higher than 1.71
0.53 in sHT due to CRF (P < 0.05). Seven of the patients with CRF
had Na/K flux ratios lower than 1.5 (a value similar to that of eHT)
with a significant negative correlation with serum BUN values (r =
0.57; P <0.05). In conclusion, rather than being a genetic marker, the
alteration in the net Na/K flux ratio in patients with CRF and hyper-
tension can be due to the effect of uremia on the activity of Na*K
ATPase and other enzymatic systems of the cell membrane. In this sit-
uation, this technique is not useful to discriminate between eHT and
sHT.
Inhibition of infected-calculi synthesis with aceio-hydroxamic acid
(AHA). P. Barceló, F. Dalet, E. Boquet, and J. Onieva. Instituto de
Urologia, Nefrologia y Andrologia, Fun dación Puigvert, Barcelona,
Spain. Once the biosynthetic molecular basis of the ureogenerated cal-
culi were known, we proceeded to inhibit them with a chemical analo-
gous of urea—acetohydroxamic acid. Healthy urine samples were in-
oculated with Proteus n?irobilis (5.4 x 106 CFU/ml) in the presence of
varying concentrations of AHA: (I) chemical variations in the ele-
ments, pH urea ammonia. Mg and Pi (closed system); (2) "in vitro"
inhibition of synthesis of calculi-like substances; (3) investigation of the
mechanisms of action of AHA with a IL-9l9 analyzer. In the closed
system, an increase in ammonia production, pH levels and a urea-de-
creasing were observed in the absence of AHA. Minimum differences
in these elements were also observed with concentrations of 100 sg/ml
of AHA. No changes in Mg and Pi were seen in the presence of dif-
ferent concentrations of AHA. Calculi-like substances were produced
without AHA, and no calculi were formed with 100 sg/ml. The study
of enzymatic kinetics showed that AHA acts as a progressive inhibitor
of urease by the formation of an inactive and steady complex 'in vi-
tro" that is able to stop in the first step, the biosynthetic process of
infected calculi.
Idiopathic mesangial glomerulonephritis (1MG). J. Ba//arm, P.
Barceló, J. Mora, C. Gelpi, F. Algaba, J. L. Rodriguez, and G. Del
Rio. Fundoción Puigi'ert, Barcelona, Spain. 1MG is defined by a pro-
liferation of mesangial cells or a matrix increase. lmmunofluorescence
(IF) enables the separation in four entities: IgA, 1gM, C1. or negative
IF. We have studied 119 patients: 72 with MGIgA, 21 MGIgM, 18
MGC5, and 8 MG with negative IF. Presentation in lgA was protein-
uria and hematuria (PH) 66.7%; isolated hematuria (IH) 26.4%; nephrot-
ic syndrome (NS) 5.5%: isolated proteinuria (P) 1.4%. Presentation in
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1gM was IH 38,1%; PH 19%; NS 42.8%; in C3: IH 55.5%; PH 27.8%;
NS 16.6%; in negative IF: IH 37.5%; P 12.5%; NS 50%. The follow-up
was: in MSIgA (76 36 months) 16.7% with renal failure (RF). Out of
four NS one remission was observed; in the other ones the NS per-
sisted with RF. In MGIgM (64.6 59 months) 14.3% with RF. No re-
mission was observed in the five non-treated NS (two with RF). Out
of the four treated NS (corticosteroids (c) o c + ciclophosphamide(CF), one had remission, Iwo were C resistant and one was C-depen-
dent. In MGC3 (23 22 months) one patient with slight RF; out of the
three with NS, there was one spontaneous remission and two with C.
In negative IF (39 37 months) there was no RF, one NS had remis-
sion without C, two had remissions with C and one was C resistant.
The 1MG with hematuria have a good prognosis. MG 1gM with NS have
good response to C or CF in 70% of instances. MGC3 and negative IF
have a less defined clinical entity.
Localization of DR antigens in normal human kidney. P. Arriza-
balaga, E. !Viirapeix, R. Vilella, A. Torras, J. Andreu, A. Darnell, and
L. Revert. Nephrology Service, immunology Laboratory, Hospital
Clinic University of Barcelona, Barcelona, Spain. Cells that express
DR antigens have potent antigen presenting and mixed lymphocyte cul-
ture-stimulating properties. DR antigens are widely distributed in cells.
We have studied their localization in normal human kidney (NHK). We
have obtained and used a mouse nionoclonal antibody directed against
a monomorphic determinant of DR (EDU-l) with an indirect im-
munofluorescence (IF) technique on five specimens of normal human
tissue. Nuclear counterstaining with ethidium bromide was used for
cellular localization. Tonsil sections and peripheral blood cells were
used for the control of DR antigens. Monoclonal antibody to no DR
antigens (Cris-l) and ascite fluid of myeloma-NSI were used to avoid
nonspecific fixation. We observed heavy IF (DR antigens) in the renal
interstitium and the glomerular capillaries. In addition, bright staining
was observed in the mesangium. Occasionally, DR antigens were lo-
calized around nuclear structures. This shows that in NHK, the DR an-
tigens are localized in cellular structures, probably vascular endothe-
hal cells of intertubular and glomerular capillaries. This study shows
that within the NHK, there are fixed cells with immunostimulatory ca-
pacity.
Chemical bases of infected-calculi synthesis. F. Dalet, J. Onieva, E.
Boquet, and P. Barceló. Urolog,' and Nephrology inslilute (Puigvert
Foundation), Barcelona, Spain. The relation between the ureolithic
germs (UG) and the formation of struvite (ST) calculi was known early
in the present century. The presence of UG (85%) into 100 infectious-
calculi core and in vitro production of ST intracolonial crystals (Pro-
teus mirabilis + urine + agar) has previously been demonstrated in
our lab. In vitro reproduction of calculi-like (P. mirabilis + urine) and
the study of Ca, Pi, Mg, Ni-I4, urea, uric acid, CO3H and pH urinary
changes, when ureolysis takes place, were performed. The equimol-
ecular concordance between empirical/structural formulation was veri-
fied and a biosynthesis scheme was proposed. Microbial (P. mirabilis
4.5 x 106 UFC/ml) and vegetal (jack-beans: 18 UI/mI ureases were
used. One week later, a calculi-like (0.8 x 1.5 cm) composed in 99%
by ST + carboxiapatite (CA) + diamonic urate (AU) was obtained.
During ureolysis 1/3 CO3H + 2 OH + I NH 4/urea molecule are
produced with both urease types. CO3H- and OH- react with Ca +
PO4 to give unsolvable CA + 14/3 H -- hydroxiapatite. NH4 reacts
with Mg + PO4 + uric acid obtaining unsolvable ST + AU + 4 H.
In theory, a total of 36 OH— (1st step) against 36 H (2nd step) are
produced per molecule of hydrolized urea, but in practice there is an
excess of OH- due to insufficient Ca and Pi urinary concentrations.
So, pH increases from 5,5 (basal) up to 9.1 (final). We concluded that
the validity of the biosynthesis scheme allows a clear approach to the
pharmacological treatment of infectious-calculi relapses.
Alteration of postsynaptic adrenergic receptors in chronic hypotension
associated with terminal uremia. A. Martinez-Vea, A. Boley, J. Gaya,
J. Montoliu, J. López-Pedret, and L. Revert. Hospital ClInico, Bar-
celona, Spain. The elevation in norepinephrine (NE) plasma levels
(both basal and orthostatic) and the resistance to the pressor action of
a NE infusion in six chronically hypotensive hemodialysis patients
(group 1) suggested a postsynaptic adrenergic alteration. To determine
if this defect is located in the vascular wall or in the adrenergic recep-
tor, we infused angiotensin II (All) at progressively increasing doses
of 2 to 12 ng• kg-' min' i.v. in patients from group 1, in six nor-
motensive hemodialysis patients (group 2) and in six healthy control
subjects (group 3). All infusion induced similar increments in mean ar-
terial pressure in all groups: maximal increment in group 1 21.5 5.1
mm Hg, in group 2 24.4 7.4 mm Hg, and in group 3 19.4 2.7 mm
Hg (P NS). All induced a decrease in heart rate in group I, but not
in group 2 (maximal increment in heart rate —5.1 2.2 vs. 2.7 1.5,
respectively, P < 0.02). Heart rate in group 3 behaved as in group I.
These results demonstrate that the postsynaptic defect of chronically
hypotensive hemodialysis patients is not due to an alteration of the ves-
sel wall but is rather located in the adrenergic receptor. Since in these
patients All decreases heart rate, the baroreceptor reflex must be pre-
served.
Increase in serum potassium caused by beta-2 adrenergic blockade in
terminal renal failure: Absence of mediation by insulin or aldosterone.
P. Arrizabalaga, J. Montoliu, A. Martinez- Vea, L. Andreu, J. Lopez-
Pedret, and L. Revert. Nephrology Service, Hospital Clinic, Univer-
sity of Barcelona, Barcelona, Spain. Beta adrenergic stimulation has
been shown to facilitate intracellular potassium (K) uptake, both in
normal subjects and uremic patients. Accordingly, beta blockade might
be expected to impair K tolerance in terminal renal failure. To test this
hypothesis, we gave propranolol, and then atenolol, to a group of 12
clinically stable nondiabetic patients (mean age, 54 years) on chronic
hemodialysis (HD) and a constant diet containing approximately 50
mEq of K/day. Propranolol, 60 to 80 mg/day for 10 days, induced a sig-
nificant increase in pre-HD serum K from 5.1 0.1 to 5.8 0.2
mEq/liter (P < 0.005). The use in the same group of patients of ateno-
lol (50 mg/day for 10 days) did not produce a significant change in pre-
HO serum K (5.5 0.2 to 5.2 0.2 mEq/liter). Both propranolol and
atenolol decreased heart rate (72 2 to 66 2 and 76 3 to 62 3
bpm, respectively, P < 0.02 for both). Neither propranolol nor ateno-
lol induced significant changes in pre-HD plasma aldosterone, arterial
pH, serum insulin, or blood glucose. This shows that in HO patients,
beta-2 adrenergic blockade by propranolol is associated with a signifi-
cant increase in serum K not mediated by pH, aldosterone, or insulin,
and probably due to the inhibition of intracellular K uptake. Selective
beta 1 adrenergic blockade by atenolol at low doses does not change
serum K, and therefore, if indicated in HD patients, cardioselective
beta blockers might be preferable to nonselective drugs.
Renal function during open heart surgery: Effect of cardiopulmonary
bypass. E. Sancho, R. Guerrero, A. Martin-Malo, E. Andres, E. Mo-
reno, F. Alvarez, and P. Aljama. Ciudad Sanitaria "Reina Sofia," Cor-
doha, Spain. Acute renal failure (ARF) attributable to open heart sur-
gery is multifactorial. We have examined the role of preoperative re-
nal function and extracorporeal circulation as determinant causative
factors. The study was undertaken in 68 consecutive patients: glomer-
ular filtration rate (GFR), fractional excretion of sodium (FENa) and
enzymuria expressed as mU/min/GFR x 100 including N-acetyl-
glycosamine (NAG), alanineaminopeptidase (AAP), leucineaminopep-
tidase, and alkaline phosphatase. These measurements were obtained
1 day preoperatively, intraoperatively (INT), and I day postopera-
tively (POS). There was no deterioration of renal function by conven-
tional criteria in 45 patients (—A), whereas 23 developed postoperative
ARF (—B).
Main results (i.l%):
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—A 55"
—9
—B 18a 55a
a P < 0.05.
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Patients -A showed a GFR significantly greater preoperatively when
compared with -B (P < 0.005). There was a positive correlation be-
tween the time of duration of the bypass and urinary NAG (r = 0.86).
These data suggest that the cardiopulmonary bypass itself induces re-
nal dysfunction, since significant enzymuria can be demonstrated even
in patients with normal GFR. The degree of preoperative renal func-
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tion and prolonged cardiopulmonary bypass time are determinant fac-
tors of ARF in relation to open heart surgery.
Vaccination against hepatitis B in a dialysis unit. F. EscuIn, J. Con-
esa, P. GOmez, A. Rodriguez Carmona, 0. Ortega, E. Huarte, M.
Perez FontOn, and L. Sanchez Sicilia. Ciudad Sanitaria "La Paz,"
Madrid, Spain. This study was undertaken to analyze immune re-
sponse, tolerance, and side effects of the hepatitis B vaccine in the pa-
tients and staff of our dialysis unit. Subjects were included in the trial,
provided they fulfilled the following criteria: older than 18 years of age,
nonpregnant, written agreement, no hepatitis B virus markers (RJA,
ABBOTT), normal transaminases levels (SMAC - II). At T0, T1 month
and T5 months, 34 patients and 59 staff members were administered
three doses of vaccine consisting of 20 g (staff) or 40 g (patients).
After a 9-month follow-up, 93% of personnel and 87.9% of the patients
developed protective antibodies. Anti-HBs titers were significantly
higher among staff than in patients. Among patients, no statistical dif-
ference was observed in anti-HBs titers in relation to age group, sex,
and dialysis procedure. However, patients with nephroangiosclerosis
developed lower anti-HBs titers than the other groups of renal pa-
tients.
Suppressor cell activity in hemodialysis patients. E. Mirapeix, J. Mon-
toliu, C. SuOrez, J. López-Pedret, and L. Revert. Servicio de
Nefrologia, Hospital Clinico y Provincial, Barcelona, Spain. The im-
munologic alterations in patients under hemodialysis (HD) are only
partially understood. We studied the Concanavalin A (Con A) induced
suppressor cell activity (SCA) of irradiated and nonirradiated cells in a
mixed lymphocyte culture (MLC). Peripheral blood lymphocytes
(PBL) from 14 normal individuals and 14 patients on regular hemodi-
alysis were incubated for 48 hr with 10 and 40 g of Con A. Irradiated
and nonirradiated cells were then tested in their capacity to suppress a
standard unidirectional MLC. The proliferative response to phito-
hemaglutinin (PHA) of cells from HD patients and controls was also
determined. The results were: (1) SCA of PBL incubated with 40 zg
of Con A and irradiated was significantly lower in HD patients (25.8
18.8%) than in controls (46 10%) (P < 0.001). (2) PBL incubated
with 10 ,ug of Con A and irradiated, and cells incubated with 10 and 40
tg of Con A nonirradiated had similar SCA to that of controls. (3) The
proliferative response to PHA was similar or even slightly higher in
PBL from patients on HD than in controls. In conclusion, (1) the nor-
mal SCA of nonirradiated cells and the normal proliferative response
to PHA, suggest that the T cell population of HD patients has no in-
trinsic functional defect. (2) The presence of an abnormal SCA in the
irradiated cells indicate that the radio-resistant subpopulation has a
functional defect. The cell responsible for this suppressor defect prob-
ably belongs to the monocyte/macrophage population because of its ra-
dio-resistance.
Abnormalities of the immune regulation of IgA by tonsil lymphocytes
of patients with IgA nephropathy. L. Lozano, R. Blasco, J. Sancho, R.
Garcia-Hoyo, and J. Egido. Servicio de Nefrologia, Fundacion Jime-
nez Diaz, Madrid, Spain. Previously, we have demonstrated that pa-
tients with IgA nephropathy have high serum levels of polymeric IgA
due in large part to their elevated synthesis by peripheral lympho-
cytes. Since these patients often present macroscopic hematuria fol-
lowing respiratory tract infections, we have studied the possible ex-
istence of immunological abnormalities in the tonsils of patients with
IgA nephropathy. Subsets of T lymphocytes were established by stand-
ard monoclonal antibodies. The Ig-bearing lymphocytes were deter-
mined by rosetting and the proportion of polymeric IgA-synthesizing
lymphocytes were measured by a secretory component binding assay.
Patients with IgA nephropathy showed a significant increase in IgA
bearing lymphocytes and the proportion of cells producing polymeric
IgA. There was also a higher production of IgA by patient B cells than
control B cells when co-cultured with allogeneic control T cells.
Furthermore, an increase in the OKT4/OKT8 cell ratio was ob-
served in these patients. These data suggest the existence of an im-
munoregulatory dysfunction in the secretory immune system of pa-
tients with IgA nephropathy.
Phenytoin in the treatment of IgA nephropathy. Results of a long-term
study. J. Egido, F. Rivera, J. Sancho, and L. Hernando. Servicio de
Nefrologia, Fundacion Jimenez Diaz, Madrid, Spain. The final report
of a long-term non-randomized controlled trial of phenytoin therapy in
patients with IgA nephropathy is presented. The mean time period of
follow-up was of 17 months (range, 6 to 48) in the treated group (41
patients) and of 14 months (range, 6 to 36) in the non-treated group (32
patients). Both groups were comparable in age, sex, onset of the
nephropathy, blood pressure, and renal function. The number of epi-
sodes per year of macroscopic hematuria decreased in both groups but
was significantly lower at each time period in the treated group than in
the control one. The diminution of microhematuria only occurred in the
treated group. One patient in each group developed advanced renal
failure. The mean serum IgA concentration diminished significantly in
the treated group, as early as 6 months, but not in the non-treated
group. There was a certain association between the presence of the
HLA A2 and BW 35 antigens and the lowering of serum IgA. A nor-
malization of the high serum levels of polymeric IgA occurred in the
treated patients. A marked diminution of the Raji IgA-immune com-
plexes, well correlated with hematuria, was only observed in the
treated group. However, despite the diminution of the serum IgA lev-
els, the disappearance of the potential pathogenic IgA immune com-
plexes and the hematuria in a number of treated patients, a progres-
sion in the percentage of global or focal glomerular sclerosis and/or
vasculointerstitial lesions was seen in some of them. It is concluded
that phenytoin decreases the clinical activity and correct some of the
immunological alterations of a certain number of patients with IgA
nephropathy but have no valuable effects on the renal lesions. The
overall results of this trial do not suggest the employment of this drug
in patients with IgA nephropathy and normal renal function. Our data
also suggest that non-immunological mechanism may be of importance
in the progression of chronic renal damage in this disease.
Presence of auto-anti-idiotypic antibodies during the immune response
to dietary antigens in IgA nephropathy. J. Sancho, J. Gonzalez, and J.
Egido. Servicio de Nefrologia. Fundacion Jimenez Diaz, Madrid,
Spain. We have recently shown that approximately 50% of patients
with IgA nephropathy had immune complexes (1C) containing antibod-
ies against diet antigens (ovoalbumin, BSA) and that 2 to 4 hr after a
food challenge there was a decrease in these IC, as well as in igA-IC,
with a subsequent rise to fasting levels at 6 hr. In the present study
circulating auto-anti-idiotypic antibodies were examined in two pa-
tients having high serum levels of anti-BSA antibodies. Around 80% of
these antibodies belong to the IgA class and 8% to the IgG class. The
specificity of these antibodies to the BSA was conveniently proved in
ELISA assay with the BSA coated to the polystyrene plates. Until now
only the IgG with binding affinity for the anti-BSA has been isolated
from both sera after another step on affinity chromatography. Pooled
human gamma globulin and aggregated IgG did not inhibit binding of
specific anti-anti BSA to the corresponding anti-BSA, but BSA did
block this binding indicating that some of these antibodies have at'-
finity for the BSA-binding site. These studies suggest that in patients
with IgA nephropathy anti-idiotypic antibodies do participate in vivo
immune complex formation, competing with dietary antigens for bind-
ing sites on the anti-BSA antibody.
Long.term follow-up of six patients with distal tubular acidosis. I.
Guardia, F. CastellO, L. Ca/us, and G. Fortuny. Pediatric Nephrol-
ogy Department, Hospital Infantil, Ciutat Sanitaria de Ia Vail
d'Hebron, Barcelona, Spain. Four patients with distal tubular acido-
sis, Type III (two with deafness) and two with Type I, presented with
polyurea, weight and height retardation, hyperchloremic metabolic aci-
dosis: K 2.5 mEq/liter; Ca/Cr0 0.2 to I; %PTR 33 to 85%; Max U
Osm: 150 to 450 mOsm/kg. GFR was normal in all of the patients.
Other measurements were: NH4CI overload; minimum 5.7 to 6.7;
A.T. (T = 13.5 4.3); NH4 (1 = 44.3 12); H (T = 57 13)
mEq/min/l .73 m3, bicarbonate threshold, 7 to 20 mEq/liter; fractional
excretion of bicarbonate 3 to 12.5%; z Pco2 (O-S) 5 to 8 mm Hg. Hypo-
tonic hydrosaline infusion was performed in patients whose sodium bi-
carbonate loss gave the following results: CIH2O + ClNa 22 to 25;
CINa 8 to 10 ml/min/100 GFR; CIH2O/CIH2O + CINa 60 to 62%.
These data improved progressively at the same time as the proximal
tubular bicarbonate and sodium reabsorption. X-rays revealed neph-
rocalcinosis was present in three patients, moderate in two, and absent
in the other one. The patient were treated with the doses of bicarbo-
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nate necessary to reach normal serum bicarbonate concentrations and
normal urinary calcium excretion that were related to urinary bicarbo-
nate loss and to the age of those having a significant regression line(r = — 0.86, P < 0.002; 4 to 7 mEq/kglday up to 6 years and 2 to 3
mEqlkglday afterwards. These patients were followed for 13 years.
Urinary calcium excretion normalized significantly in relation to the se-
rum bicarbonate concentration (y = 11.51 — 0.45X; r = 0,81y; P <
0.0005); hypostenuria improved in patients with moderate nephrocal-
cinosis. CIk decreased; %PTR and GFR are normal and growth con-
tinues normally. In summary, only constant normalization of serum bi-
carbonate concentration prevents the appearance and progression of
nephrocatcinosis and permits optimal growth.
Sodium chloride-losing syndrome in five patients with Bartter syn-
drome. A. Vila, F. Caste/b, L. Cailis, and G. Fortuny. Pediatric
Nephrology, Department Hospital Infantil, Ciutat Sanitaria de Ia Vail
d'Hehron, Barcelona, Spain. Tubular sodium reabsorption was stud-
ied in five patients with Bartter syndrome when they were 2, 7, 15, 22.
and 32 years of age, respectively. Distal sodium delivery was very high
in the two youngest patients (36.0 and 29.2) and almost normal in the
other three (11.7, 14.7, and 17; Nl, 14.6 1.7 ml/min/dl GFR). So-
dium clearance was also very high in the first two patients (23.6 and
21.7) and slightly high in the other three (4.76 and 4.2; NI, 2.0 0.4
mI/min/dI GFR). The percentage of distal tubular sodium reabsorption
was very low in the first two patients (34 and 35%) and moderately low-
ered in the other three (60, 67, and 75.2%; NI, 86.5 1.7%). The sec-
ond patient (7 years old at first examination) was re-examined at 11 and
15 years of age; great improvement was observed. In conclusion, the
anomaly explored which is basic in the physiopathology of Bartter syn-
drome, even in the most severe cases, improves progressively with
age.
Potassium physiopathology in cystinosis. F, Castelló, E. Vilaplana, G.
Fortuny, A. Vila, and L. Caills. Pediatric Nephroiogy, Department
Hospital Infantil, Ciutat Sabitaria de Ia Vail d'Hebron, Barcelona,
Spain. Potassium physiopathology is studied in seven patients with
cystinosis. Analytical data are as follows: serum potassium concentra-
tion, 3.34 0.96 mEq/liter (NI: 4.6 0.4); fractional urinary potas-
sium excretion (CK/CCr x 100); 45 11 (NI: 10.17 2.58); urinary
aldosterone excretion; 71.33 32.2 mmoles/24 hr (NI: 26.3 17.5);
UAId,, V/Ks; 18.1 3.9 (NI: 4.76 2.39; P < 0.001 for all these pa-
rameters). At the same level of GFR impairment, CK/C >< 100 was
higher in cystinotic patients than in other patients with chronic renal
failure. In patients with cystinosis there is a sodium and bicarbonate
losing syndrome. During hypotonic hydrosaline diuresis, the sodium
loss proved to be of proximal origin, and there was a correlation among
fractional volume (m.v./C10 x 100) vs. CK/Clfl x 100 (r = 0.775); distal
sodium delivery (C,0 + CNa/CIfl >< 100) vs. CK/CIfl X 100 (r = 0.668);
fractional sodium excretion (CNa/CIfl X 100) vs. CK/Cth x 100 (r =
0.749) (P 0.01). Potassium loss could be related to the proximal tubu-
lar bicarbonate reabsorption, as well as to distal sodium reabsorption
due to hyperaldosteronism, present. Hydrochiorothiazide improves
proximal tubular abnormalities in cystinotic patients, but increases
fractional clearances of sodium and chloride, reducing reabsorption at
the Henles loop level. This effect and high aldosterone excretion in-
crease CK/Cjfl x 100.
